US SEC Trading Suspension Halt Orders — October 20, 2026

Trading suspension of common stock and warrants scheduled for October 23, 2026 at market open unless a hearing is requested by 4:00 p.m. ET October 21; a Panel hearing has been requested, staying suspension 15 days

Company has been non-compliant with Listing Rule 5250(c)(1) since repeated staff notices (April 17, May 21, August 20, 2026); compliance deadline ran through October 12, 2026

Nasdaq granted 180 extra days to April 19, 2027 to cure the $1.00 bid price deficiency, conditioned on a stated intention to use a reverse split if needed; trading is not suspended

Bid-price deficiency notice issued October 7, 2026 after 30 consecutive business days below $1.00 (Aug 25 to Oct 6); compliance deadline April 5, 2027, with no immediate effect on listing

Voluntary transfer of principal listing from NYSE to Nasdaq Global Select, ticker unchanged, NYSE trading ends November 4 and Nasdaq trading begins November 5, 2026; administrative, not a compliance event

Company says it expects to file the Q2 2026 10-Q as soon as practicable, with its 2025 10-K (July 10) and Q1 10-Q (October 8) already on file, so filing the Q2 report is the single item that could end the delinquency

Suspension of SEGG common stock and LTRYW warrants on October 23, 2026 with Form 25-NSE filing to delist if the Q2 10-Q is not filed and the Panel does not extend the stay; no assurance is given on timing

Three prior staff notices (April, May, August 2026) on the same Rule 5250(c)(1) deficiency indicate a recurring reporting-controls problem rather than a one-time lapse

If the $1.00 bid price is not regained by April 19, 2027, a delisting notice follows; a Hearings Panel appeal would NOT stay suspension, so a failed cure would carry immediate trading consequences

The extension is explicitly conditioned on a reverse split if necessary, implying dilution and share-count changes are a probable path

Sustained sub-$1.00 closing prices for 30 consecutive business days; a reverse split, if used, must be completed at least ten business days before April 5, 2027, so the decision point is roughly early-to-mid March 2027

Filing flags possible implementation delays and potential market disruption during the NYSE-to-Nasdaq switch, a short-term liquidity and trading-noise risk for HLT holders around November 4-5

Lottery.com's missed 10-Q shows that late-filing risk can escalate to suspension within a single reporting cycle, a risk for other microcap filers with Nasdaq exposure

Filing the Q2 2026 10-Q before the October 23 suspension date or obtaining a Panel stay would remove the immediate delisting risk; a clean filing is the binary catalyst to watch [OPPORTUNITY - speculative, high volatility]

With 180 days of runway and an explicit reverse-split pathway, a company that already meets other Capital Market initial listing standards could regain compliance in a structured way; watch for proxy filings authorizing a reverse split

Listing transfer effective November 5 with unchanged ticker may create index-rebalancing and flow activity around the switch date; the filing gives a precise calendar anchor

Stock price recovery above $1.00 for 10 consecutive business days before April 5, 2027 would cure the deficiency without reverse split, a defined milestone for event-driven positioning

The four filings show a clear hierarchy of severity (suspension date, Panel-stay mechanics, extended runway, no immediate effect), which can be used to rank Nasdaq-notice names by time-to-consequence

Four of four filings are Nasdaq compliance notices, split between timeliness (1) and minimum bid price (3 incl. SHF and XWELL); the stages show a consistent ladder of staff notice, cure window, Panel hearing, and delisting, with only the timeliness case reaching a suspension date [implication: time-to-consequence varies sharply by deficiency type]

Two of four filings (SHF Holdings and XWELL) involve the $1.00 minimum bid rule with 180-day cure windows ending in April 2027, suggesting a common low-price cohort on Nasdaq Capital Market that may face reverse-split activity in Q1 2027 [implication: expect proxy and reverse-split filings in early 2027]

Lottery.com's hearing request stays suspension, while SHF notes a hearing request would NOT stay suspension; this contrast shows that the procedural path, not just the deficiency, determines near-term trading risk [implication: read the stay terms in every notice]

Hilton's move from NYSE to Nasdaq illustrates a non-distress exchange transfer, a category to separate from compliance-driven delistings in any screen of listing events [implication: filter voluntary transfers out of distress-based alerts]

Q2 2026 Form 10-Q filing status and Panel hearing outcome; hearing request deadline 4:00 p.m. ET October 21, 2026, suspension date October 23, 2026

Whether the Panel grants the extended stay the company has requested; any Form 25-NSE filing if the stay lapses

Proxy or board action authorizing a reverse split; compliance deadline April 19, 2027

Daily closing bid trend toward $1.00; reverse-split decision window ahead of the ten-business-day cutoff before April 5, 2027

NYSE final trading day November 4, 2026 and Nasdaq first trading day November 5, 2026; watch for implementation delays flagged in the filing

New Rule 5250(c)(1) and 5550(a)(2) notices in the next 30 days, as additional microcap filers with late reports or sub-$1.00 prices could enter the same pipeline